Karyopharm Therapeutics Inc.
KPTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001503802
In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $206.8M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Karyopharm Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 154 | 134 | −20 |
| Shares | 59.0M | 57.4M | −1.58M (−2.7%) |
| Value | $608.7M | $334.4M | −$274.3M (−45.1%) |
New holders (14)
Institutions that held Karyopharm Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DuPont Capital Management Corp | 73,295 | $427.0K | 0.01% |
| GFG Capital, LLC | 53,150 | $309.0K | 0.10% |
| Banque Cantonale Vaudoise | 50,000 | $291.0K | 0.01% |
| SG Americas Securities, LLC | 42,199 | $246.0K | 0.00% |
| SG3 Management, LLC | 25,000 | $146.0K | 0.05% |
| Bridgefront Capital, LLC | 20,946 | $122.0K | 0.13% |
| E Fund Management Co., Ltd. | 20,522 | $119.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 17,613 | $102.0K | 0.00% |
| XTX Topco Ltd | 16,272 | $95.0K | 0.03% |
| Commonwealth Equity Services, LLC | 12,740 | $74.0K | 0.00% |
| Point72 Hong Kong Ltd | 10,774 | $63.0K | 0.00% |
| Berman Capital Advisors, LLC | 641 | $3.00K | 0.00% |
| Dark Forest Capital Management LP | 425 | $2.00K | 0.00% |
| Quantbot Technologies LP | 308 | $1.00K | 0.00% |
Sold out (34)
Institutions that held Karyopharm Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.